shot-button
Lake Levels Lake Levels
Home > Mumbai > Mumbai News > Article > Navi Mumbai 2 Nigerians held with methaqualone worth Rs 2580 lakh

Navi Mumbai: 2 Nigerians held with methaqualone worth Rs 25.80 lakh

Updated on: 18 April,2022 04:04 PM IST  |  Mumbai
PTI |

Nizkusi Chinanso Agustin and Nizkusi Ekene Augustin have been arrested under Narcotic Drugs and Psychotropic Substances (NDPS) Act provisions and a probe into their peddling network was underway

Navi Mumbai: 2 Nigerians held with methaqualone worth Rs 25.80 lakh

Representative image

Two Nigerian nationals have been arrested allegedly with methaqualone, a synthetic depressant used illegally as a recreational drug, an official of the Navi Mumbai Anti Narcotics Cell said on Monday.


The two were nabbed near a mall on April 15 based on a tip-off and 258 grams of methaqualone worth Rs 25.80 lakh were seized, said Assistant Commissioner of Police (Crime) Vinayak Vast.


Nizkusi Chinanso Agustin and Nizkusi Ekene Augustin have been arrested under Narcotic Drugs and Psychotropic Substances (NDPS) Act provisions and a probe into their peddling network was underway, the ACP added.


This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK